mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |